Skip to main content
F
Formulate
Jobs
Companies
Drugs
Advisor
NEW
Insider Intel
Salary
Pricing
Toggle theme
Toggle theme
Menu
argenx Jobs | Formulate
Jobs
argenx
argenx Jobs
Belgium - Zwijnaarde
Biotechnology
argenx is a life sciences company focused on Antibody therapies.
171
open positions at argenx
View Full Profile
Global Medical Safety Lead
argenx
Posted 3d ago
Remote
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Senior
H-1B · 1 FY23
Head of Procurement, Corporate Services
argenx
Posted 3d ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
Executive
H-1B · 1 FY23
Rheumatology Territory Business Manager, Austin, TX
argenx
Posted 6d ago
Austin
$140K - $193K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Head of Procurement, Marketing & Sales
argenx
Posted 6d ago
Boston, MA, USA
$204K - $333K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
Executive
H-1B · 1 FY23
Neurology Territory Business Manager, Little Rock/Jackson (Overlay)
argenx
Posted 1w ago
Little Rock, AR
$140K - $193K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Neurology
MANAGER
H-1B · 1 FY23
Neurology Territory Business Manager, Nashville (Overlay)
argenx
Posted 1w ago
Nashville; Knoxville; Memphis
$140K - $193K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Neurology
MANAGER
H-1B · 1 FY23
Neurology Territory Business Manager Chattanooga, TN
argenx
Posted 1w ago
Chattanooga, TN
$140K - $193K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Neurology
MANAGER
H-1B · 1 FY23
Human Resources Business Partner
argenx
Posted 1w ago
Boston, MA, USA
$184K - $253K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Human Resources
Immunology
MID
H-1B · 1 FY23
Safety Evidence Medical Lead
argenx
Posted 1w ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Senior
H-1B · 1 FY23
Associate Director, Pharmacovigilance Quality Management, Global Patient Safety
argenx
Posted 1w ago
Remote
$175K - $377K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Pharmacovigilance
Immunology
Executive
H-1B · 1 FY23
Sr. Dir. Regulatory Affairs, Head of Global Labeling and Labeling Operations
argenx
Posted 1w ago
Remote
$268K - $369K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Regulatory Affairs
Immunology
Executive
H-1B · 1 FY23
Neurology Territory Business Manager - East Long Island, NY
argenx
Posted 1w ago
Stony Brook
$140K - $193K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Neurology
MANAGER
H-1B · 1 FY23
Sales & Marketing Director, Brazil
argenx
Posted 1w ago
Sao Paulo
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
Executive
H-1B · 1 FY23
Strategic Account Manager, Northwest
argenx
Posted 1w ago
Seattle
$140K - $193K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Manager, MRC Operations
argenx
Posted 1w ago
Boston, MA, USA
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Oncology
MANAGER
H-1B · 1 FY23
Territory Business Manager, Columbia SC
argenx
Posted 1w ago
Columbia, SC
$140K - $193K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Neurology
MANAGER
H-1B · 1 FY23
US Patent Attorney, Sr. Patent Counsel, Program Strategy & Development
argenx
Posted 2w ago
Boston, MA, USA; Gent, Belgium
$252K - $347K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Legal
Immunology
Senior
H-1B · 1 FY23
US Patent Attorney – Sr. Patent Counsel, Program Strategy & Litigation
argenx
Posted 2w ago
Boston, MA, USA; Gent, Belgium
$252K - $347K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Legal
Immunology
Senior
H-1B · 1 FY23
Head of Procurement Excellence
argenx
Posted 2w ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Supply Chain
Immunology
Executive
H-1B · 1 FY23
Early Development Global Regulatory Lead
argenx
Posted 2w ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Regulatory Affairs
Immunology
Senior
H-1B · 1 FY23
1
2
More pages
9
Next
Company Overview
Active Jobs
171
Pipeline Programs
88
Drug Products
2
Clinical Trials
91
View Full Company Profile
Therapeutic Areas
Neurology
Immunology
Oncology
Links
Company Website
Careers Page
Hematology
Rare Diseases